Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.48

+1.4%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1175)	7/1/2005 11:19:57 AM
From: Jibacoa	Read Replies (2) of 3722

NTII Seems to have support at the $3 level and is going over today through the resistance at the 3.40 level (from the Hs on June 20 to June 23) It has been up more than 4% today on moderate volume around 27Ks. The revenues in the March Q were 67% lower and it had a loss of $0.13/shr vs. $0.05 on the black column in 2004, but the EL for 2005 is only around $0.18/shr in spite of $0.46/shr in the first 3 Qs.<g> Revenues on the June Q in 2004 were only 0.17M <g> The EL for 2006 is around $0.08/shr. bigcharts.marketwatch.com NTII's XERECEPT,for the treatment of peritumoral brain edema, is in PIII and its Viprinex for the treatment of acute ischemic stroke has completed its PII and NTII is planning to start a PIII later this year. The active ingredient,which is made from venom of the Malayan pit viper,will be prepared by a German company and BAX will make the pills.<g> NTII reportedly has around $4.4M in cash and no significant LTD. One of the insiders bought around 18Ks in May.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next